中国血液净化

中国血液净化 ›› 2024, Vol. 23 ›› Issue (03): 165-169.doi: 10.3969/j.issn.1671-4091.2024.03.002

• 临床研究 • 上一篇    下一篇

腹膜透析患者冠状动脉钙化相关血清学标志物的筛选及预测价值研究

程红娟   吴晓蓉   周 威   曾 鸣   

  1. 210000 南京，1 南京医科大学第一附属医院肾内科
    211300  南京，2 南京市高淳人民医院肾内科
  • 收稿日期:2023-09-21 修回日期:2023-12-16 出版日期:2024-03-12 发布日期:2024-03-12
  • 通讯作者: 曾鸣 E-mail:940678033 @qq.com
  • 基金资助:
    南京市卫生科技发展专项资金(YKK22246)

Screening and predictive value of serum markers related to coronary artery calcification in peritoneal dialysis patients

CHENG Hong-juan, WU Xiao-rong, ZHOU Wei, ZENG Ming   

  1. Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China; 2Department of Nephrology, Nanjing Gaochun People's Hospital, Nanjing 211300, China
  • Received:2023-09-21 Revised:2023-12-16 Online:2024-03-12 Published:2024-03-12
  • Contact: 210000 南京，1 南京医科大学第一附属医院肾内科 E-mail:940678033 @qq.com

摘要： 目的 观察腹膜透析(peritoneal dialysis，PD)患者冠状动脉钙化(coronary artery calcification，CAC)的临床特征，筛选用于评估CAC的血清学标志物，并探讨其在CAC诊断中的应用价值。 方法 选取2022年3月—2023年3月在南京市高淳人民医院肾内科行PD治疗的患者，收集临床资料，完善实验室检查，ELISA法检测血清骨硬化蛋白(sclerostin)、去磷酸化未羧化基质Gla蛋白(dephospho-uncarboxylated matrix glaprotein，dp-ucMGP)、可溶性生长刺激表达基因2蛋白(soluble growth stimulation expressed gene2，sST2)水平，螺旋CT检测冠状动脉钙化积分(coronary artery calcium scoring，CACS)，根据CACS将患者分为无钙化组(CACS=0)、轻度钙化组(0＜CACS＜100)、中度钙化组(100≤CACS≤400)、重度钙化组(CACS＞400)。比较4组患者临床资料及血检指标，筛选出可用于评估CAC的血清学标志物。 结果 共纳入103例PD患者，其CAC发生率为67.96%(70/103)。4组间患者的年龄(F=9.644，P＜0.001)、透析龄(F =8.141，P=0.043)、心血管病占比(F=8.424，P=0.038)、总Kt/V(F=3.775，P=0.013)、碱性磷酸酶(F=7.909，P=0.048)、sclerostin(F=31.513，P＜0.001)、dp-ucMGP(F=24.188，P＜0.001)、sST2(F=8.691，P=0.034)、B型钠尿肽前体(F=13.922，P=0.003)水平均有差异。Logistic回归分析显示：高龄(OR=1.192，95% CI:1.070～1.327，P=0.001)、低Kt/V(OR=0.006，95% CI:0.000～0.418，P=0.018)、高sclerostin(OR=1.826，95% CI:1.194～2.792，P=0.006)、高dp-ucMGP(OR=1.990，95% CI:1.235～3.207，P=0.005)是CAC发生的独立危险因素。ROC曲线分析显示血清sclerostin、dp-ucMGP及两者联合预测PD患者CAC的曲线下面积分别为0.817(95% CI:0.715～0.919，P＜0.001)、0.797(95% CI:0.705～0.889，P＜0.001)、0.855(95% CI:0.776～0.935，P＜0.001)。  结论 血清sclerostin、dp-ucMGP是预测PD患者发生冠状动脉钙化潜在敏感的血清学标志物，有重要的临床应用价值。

关键词: 腹膜透析, 冠状动脉钙化, 骨硬化蛋白, 去磷酸化未羧化基质Gla蛋白

Abstract: Objective  To observe the clinical features of coronary artery calcification (CAC) in peritoneal dialysis (PD) patients, to find out serological markers for evaluating CAC, and to estimate their application values for the diagnosis of CAC.  Methods  The PD patients treated during March 2022 to March 2023 in the Department of Nephrology, Nanjing Gaochun People's Hospital were recruited for this study. Their clinical data were collected, laboratory examinations were improved, and serum sclerostin, dephospho-uncarboxylated matrix glaprotein (dp-ucMGP) and soluble growth stimulation expressed gene 2 (sST2) were dtermined by ELISA. Spiral CT was used to assess the coronary artery calcification score (CACS). According to CACS, patients were then divided into non-calcified group (CACS=0), mild calcified group (0＜CACS＜100), moderate calcified group (100≤CACS≤400) and severe calcified group (CACS>400). Clinical data and serum indexes were compared among the four groups, and the serological markers were then screened for evaluating CAC.  Results  The prevalence of CAC was 67.96% (70 cases) in a total of 103 PD patients. There were statistical differences in age (F=9.644, P＜0.001), dialysis age (F=8.141, P=0.043), cardiovascular disease rate (F=8.424, P=0.038), total Kt/V (F=3.775, P=0.013), alkaline phosphatase (F=7.909, P=0.048), sclerostin (F=31.513, P＜0.001), dp-ucMGP (F=24.188, P＜0.001), sST2 (F=8.691, P=0.034), and B-type natriuretic peptide precursor (F=13.922, P=0.003) among the four groups. Multivariate logistic regression showed that older age (OR=1.192, 95% CI：1.070～1.327, P=0.001), low Kt/V (OR=0.006, 95% CI：0.000～0.418, P=0.018), higher sclerotin (OR=1.826, 95% CI：1.194～2.792, P=0.006), and higher dp-ucMGP (OR=1.990, 95% CI：1.235～3.207, P=0.005) were the independent risk factors for CAC. ROC curve analysis showed that the areas under the curve of serum sclerostin, dp-ucMGP  and their combined for predicting CAC in PD patients were 0.817 (95% CI: 0.715～0.919, P＜0.001), 0.797 (95% CI：0.705～0.889, P＜0.001), and 0.855 (95% CI：0.776～0.935, P＜0.001) respectively.  Conclusion Serum sclerostin and dp-ucMGP levels are potentially sensitive serological markers for predicting CAC in PD patients, having important value for clinical application.

Key words: Peritoneal dialysis, Coronary artery calcification, Sclerostin, dp-ucMGP

中图分类号: